Keppra and Viread drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keppra (levetiracetam) and Viread (tenofovir disoproxil fumarate). Common drug interactions include acute respiratory distress syndrome among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Keppra and Viread. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
What is Viread?
Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.
77 people who take Keppra and Viread together, and have interactions are studied.

What are the common drug interactions of Keppra and Viread, by gender? *:
female:
- Acute respiratory distress syndrome
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dry eye (lack of adequate tears)
- Faecaloma (hard mass of fecal matter)
- Flatulence (flatus expelled through the anus)
- Histiocytosis haematophagic
- Osteonecrosis (death of bone)
- Pneumococcal sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae)
male:
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
- Photosensitivity reaction
- Rash erythematous (redness of the skin)
- Renal impairment (severely reduced kidney function)
- Dyspnoea (difficult or laboured respiration)
- Nausea (feeling of having an urge to vomit)
- Tooth loss
- Upper limb fracture
What are the common drug interactions of Keppra and Viread, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Oedema (fluid collection in tissue)
- Acute respiratory distress syndrome
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Emotional distress
- Histiocytosis haematophagic
- Hypertension (high blood pressure)
30-39:
- Anxiety
- Back pain
- Bone density decreased
- Bone loss
- Depression
- Mobility decreased (ability to move is reduced)
- Multiple fractures
- Osteonecrosis (death of bone)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
40-49:
- Anxiety
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Depression
- Emotional distress
- Pain
- Anaemia (lack of blood)
- Blood creatinine increased
- Renal impairment (severely reduced kidney function)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
50-59:
- Intervertebral disc degeneration (spinal disc degeneration)
- Lung disorder (lung disease)
- Multiple fractures
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Neuropathy peripheral (surface nerve damage)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Renal impairment (severely reduced kidney function)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Spinal cord compression
- Spinal fracture (fracture in one of vertebrae)
60+:
- Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
- Pain
- Anxiety
- Chronic kidney disease
- Emotional distress
- Neoplasm malignant (cancer tumour)
- Pancreas infection
- Renal disorder (kidney disease)
- Diarrhoea
- Spinal compression fracture (fracture due to spinal compression on bone)
What are the existing conditions these people have? *
- Hiv Infection: 45 people, 58.44%
- Pain: 16 people, 20.78%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 12 people, 15.58%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 11.69%
- Stress And Anxiety: 6 people, 7.79%
- Gastritis (inflammation of stomach): 6 people, 7.79%
- Otitis (ear infection): 5 people, 6.49%
- High Blood Cholesterol: 5 people, 6.49%
- Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 5 people, 6.49%
- Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 4 people, 5.19%
* Approximation only. Some reports may have incomplete information.
Do you take Keppra and Viread?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Keppra and Viread:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Viread:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keppra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Viread and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam and tenofovir disoproxil fumarate (the active ingredients of Keppra and Viread, respectively), and Keppra and Viread (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Amlodipine and Halcion - now
- Could Tylenol cause Nail Discoloration? - 4 seconds ago
- Could Paxil cause Cardioactive Drug Level Below Therapeutic? - 6 seconds ago
- Drug interactions of Amlodipine Besylate and Ziagen - 10 seconds ago
- Drug interactions of Clarithromycin and Lupron - 11 seconds ago
- Drug interactions of Norvir and Sumatriptan - 19 seconds ago
- Drug interactions of Thyrogen and Hydrochlorothiazide - 26 seconds ago
- Drug interactions of Reglan and Bactroban - 27 seconds ago
- Could Tysabri cause Kidney Stones? - 37 seconds ago
- Could Zofran cause Dissociation? - 44 seconds ago